Reach Us +1-218-451-2974


A Randomized Double-blind Placebo-controlled Study Evaluating The Role Of Saffron In Treatment Of Fluoxetine-induced Sexual Dysfunction In Women | 12461
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google scholar citation report
Citations : 2275

Journal of Alzheimers Disease & Parkinsonism received 2275 citations as per google scholar report

Journal of Alzheimers Disease & Parkinsonism peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

A randomized double-blind placebo-controlled study evaluating the role of saffron in treatment of fluoxetine-induced sexual dysfunction in women

International Conference on Psychology, Autism and Alzheimers Disease

Sepideh Saroukhani

ScientificTracks Abstracts: J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.002

Some previous experimental and human studies have shown that saffron (Crocus sativus L.) has aphrodisiac effects. The aim of the present study was to assess the safety and efficacy of saffron on selective serotonin reuptake inhibitor-induced sexual dysfunction in women. Thirty-eight married women with major depression who were stabilized on fluoxetine 40 mg/day for a minimum of 6 weeks and had experienced subjective feeling of sexual dysfunction were included in the present randomized double-blind placebo-controlled study. Patients were randomly assigned to saffron (30 mg/daily) or placebo for 4 weeks. Sexual function measurement was performed at baseline, week 2, and week 4 using the Female Sexual Function Index (FSFI) questionnaire. All side effects were systematically recorded. Thirty-four women had at least one post-baseline measurement and completed the study. Two-factor repeated measure analysis of variance showed significant effect of time treatment interaction [Greenhouse-Geisser?s corrected: F (1.580, 50.567)=5.366, p=0.012] and treatment for FSFI total score [F (1, 32) = 4.243, p=0.048]. After 4 weeks, patients in the saffron group had experienced significant improvement in total FSFI (p<0.001), arousal (p=0.028), lubrication (p=0.035), and pain (p=0.016) domains of FSFI but not in desire (p=0.196), satisfaction (p=0.206), and orgasm (p=0.354) domains. Frequency of side effects was similar between the two groups. According to our findings saffron seems to be effective to improve some of the fluoxetine-induced sexual problems including arousal, lubrication, and pain.
Sepideh Saroukhani has completed her MD at the age of 27 years from Qazvin University of Medical Sciences. She was interested in psychiatry and psychology during her student ship. Therefore, she has focus on these fields in her research activities and has published papers related to both experimental and human studies in reputed journals.